http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SI-9111886-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_944f0be5b782464c15e0c9cb802ab561
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0063
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 1991-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7628ec89c6caa5992a855945c956b1a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bee978a5cb36ed43c4cd7b76fc37cda0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfad5246ec7f0f42257a4d41d4509b8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_246362920c246643ae17ffe16f2257e9
publicationDate 1999-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SI-9111886-B
titleOfInvention Heparoan-N, O-sulphates, a process for their production and the pharmaceutical preparations they contain
abstract N,O-Sulphated heparosans consisting of chains or of a mixture of chains with a molecular mass of between 1500 and 15000 Da, characterised by a repeated disaccharide structure of formula I: <IMAGE> in which - E denotes an acetyl group in 0 to 80 % of the disaccharide units of the said N,O-sulphated heparosan, and a sulphate group and optionally a hydrogen atom in the remaining disaccharide units, - G denotes a hydrogen atom and a sulphate group, and the pharmaceutically acceptable salts of the said N,O-sulphated heparosans. Medication.
priorityDate 1990-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID100736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425965992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415805831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3083599
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24139
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457588632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546193

Total number of triples: 48.